Christmas S E
Department of Immunology, Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester, UK.
Nat Immun Cell Growth Regul. 1989;8(6):301-12.
Clones were obtained from human peripheral blood WT31-, WT31-CD4-8-, CD4-8- or Leu 7+ cells in the presence of interleukin 2 and phytohaemagglutinin. Almost all clones were CD3+, about 50% were CD4-8- and all clones tested derived from WT31- remained WT31-, indicating that they were expressing a gamma/delta heterodimer in association with CD3. Some clones derived from CD4-8- cells expressing CD3 were WT31- and some were WT31+. All CD3+ clones had T cell receptor (TCR) gamma gene rearrangements; most also had their TCR beta genes rearranged, including all clones derived from Leu 7+ cells. TCR gamma gene rearrangements were noted involving all five known J segments. There was a tendency for V gene segments from the VII and VIII subgroups to be rearranged to J gamma 2 less often than those from the more 5' VI subgroup. Two clones definitely had one rearrangement to C gamma 1 and one to C gamma 2. When clones derived from WT31- cells were considered, the only obvious relationship which emerged was that all clones with both chromosomes rearranged to C gamma 2 had low or negligible cytotoxic activity against natural killer (NK)-sensitive and NK-resistant targets. Several of these clones were expressing CD8 on about 30% of cells. Most clones with rearrangements involving only C gamma 1 had high non-MHC-restricted cytotoxicity while those with at least one C gamma 1 rearrangement had either high or low activity. The only exceptions noted were a clone with a single V9JP rearrangement and a clone with a V9JP and a VI/IIIJP1 rearrangement, which both had low activity. A similar pattern was also found with most clones derived from Leu 7+ cells. The data are consistent with the participation of most types of disulphide-linked (C gamma 1) gamma/delta heterodimers in non-MHC-restricted cytotoxic activity mediated by CD3+ gamma/delta + T cell clones.
在白细胞介素2和植物血凝素存在的情况下,从人外周血WT31-、WT31-CD4-8-、CD4-8-或Leu 7+细胞中获得克隆。几乎所有克隆都是CD3+,约50%是CD4-8-,并且所有来自WT31-的测试克隆仍为WT31-,这表明它们表达与CD3相关的γ/δ异二聚体。一些来自表达CD3的CD4-8-细胞的克隆是WT31-,一些是WT31+。所有CD3+克隆都有T细胞受体(TCR)γ基因重排;大多数也有其TCRβ基因重排,包括所有来自Leu 7+细胞的克隆。注意到TCRγ基因重排涉及所有五个已知的J片段。VII和VIII亚组的V基因片段与Jγ2重排的频率往往低于更靠近5'端的VI亚组。两个克隆肯定有一次重排至Cγ1,一次重排至Cγ2。当考虑来自WT31-细胞的克隆时,出现的唯一明显关系是,两条染色体都重排至Cγ2的所有克隆对自然杀伤(NK)敏感和NK抗性靶标的细胞毒性活性低或可忽略不计。这些克隆中的几个在约30%的细胞上表达CD8。大多数仅涉及Cγ1重排的克隆具有高的非MHC限制性细胞毒性,而那些至少有一次Cγ1重排的克隆具有高活性或低活性。唯一注意到的例外是一个具有单一V9JP重排的克隆和一个具有V9JP和VI/IIIJP1重排的克隆,它们都具有低活性。在大多数来自Leu 7+细胞的克隆中也发现了类似模式。这些数据与大多数类型的二硫键连接的(Cγ1)γ/δ异二聚体参与由CD3+γ/δ+T细胞克隆介导的非MHC限制性细胞毒性活性一致。